Comparison 6. Ketoconazole vs climbazole.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Failure to achieve complete resolution (long term)	1		Risk Ratio (M‐H, Fixed, 95% CI)	Totals not selected
1.1 Scalp only	1		Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
2 Erythema ‐ Failure to achieve complete resolution	1		Risk Ratio (M‐H, Fixed, 95% CI)	Totals not selected
2.1 Scalp only	1		Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
3 Erythema ‐ Failure to achieve complete resolution (long term)	1		Risk Ratio (M‐H, Fixed, 95% CI)	Totals not selected
3.1 Scalp only	1		Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
4 Scaling ‐ Erythema ‐ Failure to achieve complete resolution	1		Risk Ratio (M‐H, Fixed, 95% CI)	Totals not selected
4.1 Scalp only	1		Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
5 Scaling ‐ Erythema ‐ Failure to achieve complete resolution (long term)	1		Risk Ratio (M‐H, Fixed, 95% CI)	Totals not selected
5.1 Scalp only	1		Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]